When talking about the influence of pharmacy benefit managers, U.S. Sen. James Lankford exhibits a mastery of how companies like CVS Health control where patients get their medicine, what ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...

A yearslong Federal Trade Commission probe, resulting in a report released in July, reported that of the six pharmacy benefit managers investigated, three of them (CVS Caremark, Express Scripts and ...

Sysco allows restaurants to buy the bulk of its needs from a single source rather than dozens of producers, simplifying logistics and saving time. While the goods it sells are commodities, Sysco can ...

Oil and gas production in the United States is hitting record highs, easily outpacing consumption growth and fueling an export boom that in 2020 achieved the country's first trade surplus in energy ...